ArticleEuropean journal of heart failure2021

Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial.

Milton Packer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.